Malaria is still a health problem in Indonesia. The number of malaria cases according to the 2018 RISKESDAS reached 8076 cases, and the highest number was obtained from Papua province with 3,334 cases. Multiple infection malaria in Indonesia according to RISKESDAS 2018, has a rate of 0.01% of the total cases, namely Plasmodium Falciparum malaria and Plasmodium non Falciparum malaria. A 47 year old man was referred from the clinic with complaints of high fever preceded by chills 10 days before being admitted to the hospital. Accompanied by shortness of breath, unable to get off the treatment bed due to feeling very weak, nauseous, sick and having a bulging stomach. Physical examination revealed a pale conjunctiva, ronkhi in the lower field of the right lung, dim percussion in the basal of the left lung, hepatomegaly, splenomegaly, shifting dullness. ring form vivax, on chest X-ray found a left pleural effusion. It is known that the patient previously lived in Papua from September 2018 to May 2019. During treatment, the patient was given artesunate injection therapy, dihydroartemisin + piperaquine and primaquin for seven days of treatment. At the end of the treatment, another chest X-ray was performed and re-examination of the peripheral blood smear, no more pleural effusions were found and no parasites were found on re-examination of the peripheral blood smear. Mixed infection of vivax and falciparum malaria, is a rare case that may occur in endemic areas where both plasmodium can be found. The prevalence in Indonesia according to RISKESDAS is only about 0.01% of all malaria cases in Indonesia.
Hypertension is one of the leading causes of mortality and morbidity in Indonesia. Resistant hypertension is a case of hypertension whose blood pressure remains high, after a change in lifestyle and obtaining management of 3 anti-hypertensive drugs with optimal doses with a different mechanism of action. The exact prevalence of HR is not known with certainty. The lack of data on the prevalence of resistant hypertension is the aim of this study to complete the data on the prevalence of resistant hypertension in UKI General Hospital. This research is descriptive. Data is taken from UKI General Hospital medical records from January to December 2019 with inclusion and exclusion criteria. Of the 1,030 in patients with hypertension, 139 patients are suffering from resistant hypertension. With the number of men and women not very different, the average age is 58 years, and most cases are in the age group> 65 years. Chronic kidney failure (CKD) is the most common comorbid disease, followed by DM and heart failure. Patients with more resistant hypertension have very high initial blood pressure, and most use a combination of 3 drugs to control their blood pressure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.